733.43MMarket Cap
6.12P/E TTM
Zevra Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Zevra Therapeutics Inc is 7.54, ranking 124 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 6.12, which is 162.79% below the recent high of 16.08 and 2362.69% above the recent low of -138.42.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.